USPTO serial 76444543
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
81477 München, DE
81477 München, DE
81477 München, DE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
G. Patrick Sage
G PATRICK SAGE HUESCHEN & SAGE PLLC7TH FL KALAMAZOO BLDG107 W MICHIGAN AVEKALAMAZOO, MI 49007| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives all for scientific purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with florescence activated cell sorting FACS devices or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes | SECTION 8 - CANCELLED | — |
| 005 | Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases,osteoporosis, graft versus host and host versus graft diseases, transplant rejection,coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders,neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases,proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases; and minimal residual diseases; restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis,immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use, eukaryotic cells,eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture and, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micro metastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACSor with receptor/ligand binding, of cells of chemically fixed tissue, of micrometasttic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto immune diseases,inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases,restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy,rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases,neurodegenerative diseases; sanitary preparations for medical purposes, namely, agents for dental care | SECTION 8 - CANCELLED | — |
| 009 | Diagnostic and testing apparatus and systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, fluorescence activated cell sorting FACS devices, lasers, balloon instruments and magnetic devices, for scientific research purposes, all for the development of medicaments, identification and analysis of eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides | SECTION 8 - CANCELLED | — |
| 010 | Diagnostic and testing apparatus and systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, Flourescence Activated Cell Sorting FACS devices, lasers, balloon instruments and magnetic devices, for clinical medical purposes, all for the clinical diagnosis and analysis for animal and human diseases, eukaryotic cells, eukaryotic cell culture lines and animal and human material | SECTION 8 - CANCELLED | — |
| 042 | Scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, in the field of molecular biology, biotechnology, genetics, medicine, pharmacology, cell biology; identification of target structures for the development of medicaments, identification of cell growth and differentiation; determination of the pathogenesis of animal and human diseases; development of medicaments; development of technologies and means for scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, namely, of eukaryotic cells, eukaryotic cell culture lines, animal and human material, nucleic acids and polypeptides; performance of diagnoses and analyses for medical research purposes; eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 15, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 6, 2005 | DMCC | DATA MODIFICATION COMPLETED | — |
| Oct 2, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 20, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 28, 2005 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jun 28, 2005 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 24, 2005 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 26, 2005 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 18, 2005 | FAXX | FAX RECEIVED | — |
| Nov 22, 2004 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 26, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 14, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2004 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jun 19, 2004 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 10, 2004 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Mar 15, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2004 | PAPER RECEIVED | — | |
| Mar 1, 2004 | CNCF | CONTINUATION OF FINAL REFUSAL MAILED | — |
| Nov 17, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 17, 2003 | PAPER RECEIVED | — | |
| Nov 12, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 8, 2003 | CFIT | CASE FILE IN TICRS | — |
| Oct 10, 2003 | PAPER RECEIVED | — | |
| Oct 7, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2003 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 23, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2003 | PAPER RECEIVED | — | |
| May 16, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2003 | PAPER RECEIVED | — | |
| Dec 10, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2002 | DOCK | ASSIGNED TO EXAMINER | — |